Clinical Trial Update: Trial Evaluating Efficacy and Safety of Dasiglucagon in Children With Congenital Hyperinsulinism [Phase 2, Phase 3]

View source ↗

Summary

Updated results from a Phase 2/3 trial evaluating dasiglucagon for efficacy and safety in children with congenital hyperinsulinism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Hyperinsulinism

Drugs mentioned

• Zegalogue (dasiglucagon)

Snippet

Sponsor: Zealand Pharma | Conditions: Congenital Hyperinsulinism | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2025-03-14